DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 03 · Volume 31 · May 1998 DOI: 10.1055/s-002-6317

Editorial

  • 75
    Ferszt, R.; Severus, E.:

    Borna or not?

    • Original Paper

  • 77
    Dietrich, D. E.; Schedlowski, M.; Bode, L.; Ludwig, H.; Emrich, H. M.:

    A Viro-Psycho-lmmunological Disease-Model of a Subtype Affective Disorder

  • 83
    Straube, E. R.; von Eye, A.; Müller, M. J.:

    The Symmetry of Symptom Patterns in Pre-Post Treatment Designs

  • 102
    Aravagiri, M.; Marder, S. R.; Wirshing, Donna; Wirshing, W. C.:

    Plasma Concentrations of Risperidone and its 9-Hydroxy Metabolite and their Relationship to Dose in Schizophrenic Patients: Simultaneous Determination by a High Performance Liquid Chromatography with Electrochemical Detection

  • 110
    Schneider, U.; Wohlfahrt, K.; Schulze-Bonhage, A.; Haacker, T.; Caspary, A.; Zedler, M.; Emrich, H. M.:

    Lack of Psychotomimetic or Impairing Effects on Psychomotor Performance of Acamprosate

    • Review

  • 89
    Dunner, D.; Kumar, R.:

    Paroxetine: a Review of Clinical Experience

    • Case Report

  • 114
    Brown, E. Sherwood; Shellhorn, Eric; Suppes, Trisha:

    Gastrointestinal Side-Effects After Switch to Generic Valproic Acid